Dr. Charles S. Kuzma
Claim this profileFirstHealth of the Carolinas-Moore Regional Hospital
About Charles S. Kuzma
Education:
- Earned a Medical degree (MD) from an accredited medical school.
- Completed Residency training in Internal Medicine at FirstHealth of the Carolinas-Moore Regional Hospital.
- Board certified in Internal Medicine by the American Board of Internal Medicine.
Experience:
- Currently affiliated with FirstHealth of the Carolinas-Moore Regional Hospital as an Internal Medicine physician.
Area of expertise
Lung Cancer
Charles S. Kuzma has run 21 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Charles S. Kuzma has run 13 trials for Breast Cancer. Some of their research focus areas include:
Affiliated Hospitals
FirstHealth Of The Carolinas-Moore Regional Hospital
FirstHealth Of The Carolinas, Inc.
Clinical Trials Charles S. Kuzma is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting
2 awards
Phase 3
19 criteria
Chemotherapy + Immunotherapy
for Esophageal and Gastric Cancer
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting
2 awards
Phase 3
2 criteria
More about Charles S. Kuzma
Clinical Trial Related
7 years of experience running clinical trials · Led 53 trials as a Principal Investigator · 15 Active Clinical Trials
Treatments Charles S. Kuzma has experience with
- Nivolumab
- Pembrolizumab
- Atezolizumab
- Paclitaxel
- Carboplatin
- Fluorouracil
Breakdown of trials Charles S. Kuzma has run
Lung Cancer
Breast Cancer
Non-Small Cell Lung Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Charles S. Kuzma specialize in?
Charles S. Kuzma focuses on Lung Cancer and Breast Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Charles S. Kuzma currently recruiting for clinical trials?
Yes, Charles S. Kuzma is currently recruiting for 15 clinical trials in Pinehurst North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Charles S. Kuzma has studied deeply?
Yes, Charles S. Kuzma has studied treatments such as Nivolumab, Pembrolizumab, Atezolizumab.
What is the best way to schedule an appointment with Charles S. Kuzma?
Apply for one of the trials that Charles S. Kuzma is conducting.
What is the office address of Charles S. Kuzma?
The office of Charles S. Kuzma is located at: FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst, North Carolina 28374 United States. This is the address for their practice at the FirstHealth of the Carolinas-Moore Regional Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.